Plaintiffs Defeat Gilead’s Multiple Dismissal Motions in HIV Drug Kidney & Bone Injuries Litigation

On June 13, 2022, plaintiffs won a series of procedural victories in the kidney and bone injury lawsuit filed against pharma giant Gilead Sciences when California Superior Court Judge Andrew Y.S. Cheng denied three summary judgment motions filed by Gilead seeking to dismiss the litigation. Since the dangers from Gilead’s prescription medications (Truvada® and Atripla®) that

2022-06-23T17:08:50+00:00June 22nd, 2022|Personal Injury|

Sarah London Appointed to Plaintiffs’ Executive Committee in Gilead HIV Drug Kidney & Bone Injuries Litigation

On February 5, 2020, Judge Andrew Y.S. Cheng of the Superior Court for the County of San Francisco issued an order appointing Lieff Cabraser partner Sarah R. London  to the Plaintiffs’ Executive Committee in the Gilead HIV Drug Kidney & Bone Injuries Litigation. Sarah will lead the litigation on behalf of patients across California who allege they suffered kidney

2020-02-07T13:06:16+00:00February 7th, 2020|Personal Injury, Prescription Drug Injuries|

Plaintiffs Seek Relocation for Gilead Sciences Inferior HIV Drugs Trial

In lawsuits against pharma giant Gilead Sciences, plaintiffs across California allege they suffered ill effects from HIV drugs made and distributed by Gilead that were more harmful derivatives than other drugs the company had created but not sold until its stock of the inferior drugs was exhausted. As reported by the Daily Journal (subscription), attorneys

2019-08-01T14:37:20+00:00August 1st, 2019|Personal Injury, Prescription Drug Injuries|

Title